Annual summary of publications
Publications (original articles or review articles) published in 2012 from OUS - Department of Infectious Diseases
20 publications found
Antibiotic resistance in hospitals: a ward-specific random effect model in a low antibiotic consumption environment
Stat Med, 32 (8), 1407-18
DOI 10.1002/sim.5636, PubMed 23027651
Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania
Int J Infect Dis, 16 (12), e879-85
DOI 10.1016/j.ijid.2012.08.003, PubMed 23031419
A study of blood transfusion services at a district hospital in Malawi
Vox Sang, 104 (1), 37-45
DOI 10.1111/j.1423-0410.2012.01628.x, PubMed 22765350
Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS)
Clin Exp Immunol, 167 (3), 492-8
DOI 10.1111/j.1365-2249.2011.04524.x, PubMed 22288592
Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countries
Infect Control Hosp Epidemiol, 33 (10), 1008-16
DOI 10.1086/667729, PubMed 22961020
Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010
Eurosurveillance, 17 (26), 20205-26
Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010
Euro Surveill, 17 (26)
PubMed 22790534
Modulation of proximal signaling in normal and transformed B cells by transmembrane adapter Cbp/PAG
Exp Cell Res, 318 (14), 1611-9
DOI 10.1016/j.yexcr.2012.05.014, PubMed 22659621
A review of female genital schistosomiasis
Trends Parasitol, 28 (2), 58-65
DOI 10.1016/j.pt.2011.10.008, PubMed 22245065
Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years
Scand J Infect Dis, 44 (8), 566-72
DOI 10.3109/00365548.2011.653581, PubMed 22339485
Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion
Arch Intern Med, 172 (16), 1252-5
DOI 10.1001/archinternmed.2012.2719, PubMed 22826124
Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study
Blood Press, 21 (5), 311-9
DOI 10.3109/08037051.2012.680742, PubMed 22564000
Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals
J Clin Hypertens (Greenwich), 15 (2), 101-6
DOI 10.1111/jch.12029, PubMed 23339727
Impact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection
Int J Microbiol, 2012, 263836
DOI 10.1155/2012/263836, PubMed 22719767
High levels of HMGB1 in plasma may be due to ex vivo cell necrosis
Anticancer Res, 32 (9), 4067-9
PubMed 22993362
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
Arterioscler Thromb Vasc Biol, 33 (2), e47-55
DOI 10.1161/ATVBAHA.112.253427, PubMed 23162017
Infectious encephalitis: a description of a Norwegian cohort
Scand J Infect Dis, 45 (3), 179-85
DOI 10.3109/00365548.2012.719634, PubMed 23113672
External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients
AAPS J, 15 (2), 308-15
DOI 10.1208/s12248-012-9440-8, PubMed 23224752
Creating order from chaos: cellular regulation by kinase anchoring
Annu Rev Pharmacol Toxicol, 53, 187-210
DOI 10.1146/annurev-pharmtox-011112-140204, PubMed 23043438
Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation
Innate Immun, 19 (3), 290-7
DOI 10.1177/1753425912461042, PubMed 23070967